Invus Public Equities, L.P. 13D and 13G filings for Bicara Therapeutics Inc. Common Stock:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-07-31 2:56 pm Purchase | 2025-06-30 | 13G | BICARA THERAPEUTICS INC BCAX | Invus Public Equities, L.P. | 5,216,969 9.600% | 2,144,142 (+69.78%) | Filing |
| 2024-09-26 4:30 pm Purchase | 2024-09-16 | 13G | BICARA THERAPEUTICS INC BCAX | Invus Public Equities, L.P. | 3,072,827 5.700% | 3,072,827 (New Position) | Filing |